Advanced Reproductive Testing is a company that develops technologies to advance the detection and treatment of pregnancy related disorders. Established by Dr Randy Armant and Dr Drewlo, ART aims to provide clinicians and expecting parents the information needed to manage pregnancies at risk.
The team is currently developing a new product line named papseek based on next generation sequencing strategies that will enable to look for various genetic disorders from a simple pap smear as early as five weeks of pregnancy.
The technology is based on a recent publication published in the journal of Science and Translational Medicine, 11/2016.
please find press releases and the team involved: